Giuseppina Camiolo

599 total citations
17 papers, 468 citations indexed

About

Giuseppina Camiolo is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Giuseppina Camiolo has authored 17 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Giuseppina Camiolo's work include Immune cells in cancer (6 papers), Chemokine receptors and signaling (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Giuseppina Camiolo is often cited by papers focused on Immune cells in cancer (6 papers), Chemokine receptors and signaling (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Giuseppina Camiolo collaborates with scholars based in Italy and Spain. Giuseppina Camiolo's co-authors include Daniele Tibullo, Cesarina Giallongo, Francesco Di Raimondo, Giuseppe A. Palumbo, Nunziatina Laura Parrinello, Alessandra Romano, Giovanni Li Volti, Roberto Avola, Fabrizio Puglisi and Concetta Conticello and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Giuseppina Camiolo

17 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppina Camiolo Italy 11 185 145 121 121 42 17 468
A. Spyridonidis Germany 11 128 0.7× 116 0.8× 95 0.8× 171 1.4× 31 0.7× 20 434
Athanassios D. Velentzas Greece 16 89 0.5× 343 2.4× 48 0.4× 82 0.7× 54 1.3× 44 785
Cristina Micheloni Italy 13 156 0.8× 176 1.2× 91 0.8× 40 0.3× 20 0.5× 28 564
Haidong Li China 11 312 1.7× 198 1.4× 72 0.6× 10 0.1× 80 1.9× 27 683
Xuan Xie China 12 106 0.6× 135 0.9× 18 0.1× 41 0.3× 4 0.1× 29 466
Lydia Raines United States 9 182 1.0× 221 1.5× 53 0.4× 15 0.1× 32 0.8× 16 472
Cong Fu China 12 47 0.3× 207 1.4× 46 0.4× 44 0.4× 21 0.5× 16 336
Hasmik Yepiskoposyan Switzerland 10 72 0.4× 631 4.4× 73 0.6× 110 0.9× 27 0.6× 13 1.0k
Jasmin Straube Australia 12 126 0.7× 263 1.8× 110 0.9× 63 0.5× 50 1.2× 22 480
Jixian Luo China 13 129 0.7× 241 1.7× 95 0.8× 27 0.2× 11 0.3× 24 558

Countries citing papers authored by Giuseppina Camiolo

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Camiolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Camiolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Camiolo more than expected).

Fields of papers citing papers by Giuseppina Camiolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Camiolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Camiolo. The network helps show where Giuseppina Camiolo may publish in the future.

Co-authorship network of co-authors of Giuseppina Camiolo

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Camiolo. A scholar is included among the top collaborators of Giuseppina Camiolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Camiolo. Giuseppina Camiolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Romano, Alessandra, Nunziatina Laura Parrinello, Vittorio Simeon, et al.. (2020). High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling. Scientific Reports. 10(1). 1983–1983. 42 indexed citations
2.
Camiolo, Giuseppina, Alessandro Barbato, Cesarina Giallongo, et al.. (2020). Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib. Redox Biology. 36. 101611–101611. 42 indexed citations
3.
Romano, Alessandra, Nunziatina Laura Parrinello, Annalisa Chiarenza, et al.. (2019). Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma. British Journal of Haematology. 185(3). 468–479. 19 indexed citations
4.
Giallongo, Cesarina, Daniele Tibullo, Giuseppina Camiolo, et al.. (2019). TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death and Disease. 10(10). 704–704. 38 indexed citations
5.
Camiolo, Giuseppina, et al.. (2019). Evaluation of alpha-lipoic acid anti-inflammatory properties using zebrafish as in vivo model. Fish & Shellfish Immunology. 91. 389–390. 1 indexed citations
6.
Camiolo, Giuseppina, Daniele Tibullo, Cesarina Giallongo, et al.. (2019). α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload. International Journal of Molecular Sciences. 20(3). 609–609. 51 indexed citations
7.
Puglisi, Fabrizio, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.. (2019). Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3. International Journal of Molecular Sciences. 20(14). 3548–3548. 17 indexed citations
8.
Barbagallo, Ignazio, Cesarina Giallongo, Giovanni Li Volti, et al.. (2018). Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib. Molecular Neurobiology. 56(2). 1451–1460. 27 indexed citations
9.
Romano, Alessandra, Nunziatina Laura Parrinello, Katia Todoerti, et al.. (2018). Tryptophan Deprivation Promotes an Adaptive Response and Contributes to Bioenergetics in Multiple Myeloma. Blood. 132(Supplement 1). 4511–4511. 2 indexed citations
10.
Romano, Alessandra, Nunziatina Laura Parrinello, Piera La Cava, et al.. (2018). PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy. Expert Review of Molecular Diagnostics. 18(7). 675–683. 62 indexed citations
11.
Giallongo, Cesarina, Daniele Tibullo, Nunziatina Laura Parrinello, et al.. (2017). Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma. Blood. 130. 4361–4361. 1 indexed citations
12.
Tibullo, Daniele, Cesarina Giallongo, Fabrizio Puglisi, et al.. (2017). Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells. Molecular Neurobiology. 55(4). 3344–3350. 8 indexed citations
13.
Giallongo, Cesarina, Nunziatina Laura Parrinello, Piera La Cava, et al.. (2017). Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib. Journal of Cellular and Molecular Medicine. 22(2). 1070–1080. 43 indexed citations
14.
Fuochi, Virginia, Giovanni Li Volti, Giuseppina Camiolo, et al.. (2017). Antimicrobial and Anti-Proliferative Effects of Skin Mucus Derived from Dasyatis pastinaca (Linnaeus, 1758). Marine Drugs. 15(11). 342–342. 51 indexed citations
15.
Salvaggio, Antonio, Fabio Marino, Marco Albano, et al.. (2016). Toxic Effects of Zinc Chloride on the Bone Development in Danio rerio (Hamilton, 1822). Frontiers in Physiology. 7. 153–153. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026